Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
In the era of universal treatment, what are HIV clinical guidelines for?

The purpose and structure of clinical HIV guidelines may have to change radically now that universal treatment on diagnosis is the clinical consensus, physicians from the European

Published
22 December 2016
By
Gus Cairns
IDSA Guidelines Recommend Newer Tests to Diagnose Tuberculosis

Patients at risk for latent or active tuberculosis (TB) infection should be assessed with newer tests, including interferon-gamma release assays (IGRAs) and molecular diagnostics, recommend guidelines on TB diagnosis developed by the American Thoracic Society (ATS), Infectious Diseases Society of America (IDSA) and Centers for Disease Control and Prevention (CDC) and published in the journal Clinical Infectious Diseases. Advances in testing prompted the first new guidelines on TB diagnosis in 17 years.

Published
19 December 2016
From
IDSA
Ending the HIV epidemic faces daunting barriers, former WHO HIV chief warns

The difficulty of bringing the HIV epidemic “down to zero” should not be underestimated, Kevin de Cock, former director of HIV for the World Health Organization (WHO),

Published
30 November 2016
By
Gus Cairns
Underfunding ‘nightmare’ hampers the global TB battle

There is a “nightmare of underfunding” for tuberculosis (TB), described by experts as “the greatest infectious disease killer on the planet”.

Published
31 October 2016
From
Health-e
Early data indicates new regimen represents reprieve for patients with XDR TB

Data from an ongoing trial presented today indicates patients with extensively drug resistant tuberculosis for whom other treatments had failed, showed signs of full recovery from disease following a six-month regimen of two new tuberculosis drugs and one repurposed drug.

Published
31 October 2016
From
Science Speaks
TB Alliance partners with PepsiCo to advance the fight for improved medicines for children

TB Alliance, a non-profit organization dedicated to developing better and faster cures for tuberculosis (TB), today announced a unique collaboration with food and beverage company PepsiCo designed to improve the treatment for children with TB. Many of today’s TB treatments are very bitter or unpleasant in taste, which when compounded with the long duration of treatment for TB, can lead to low tolerance and poor compliance – especially among children.

Published
28 October 2016
From
TB Alliance
South Africa’s healthcare workers hard hit by TB infections

Exposure to infectious patients, high HIV rates and a lack of ventilation in facilities are some of the reasons healthcare workers in South Africa have the one of the highest tuberculosis (TB) infection rates in the world.

Published
27 October 2016
From
Health-e
Final data backs early findings, WHO recommendations, showing shorter MDR TB treatment course working better

Presenting results today of a nine month treatment regimen that led to an 82 percent cure rate among 1006 patients with multidrug-resistant tuberculosis, researchers called their findings a breakthrough that can support countries in adopting shorter, more effective and potentially less damaging treatment for TB that is resistant to more than one first line treatment.

Published
26 October 2016
From
Science Speaks
47th Union World Conference on Lung Health: Even “free” TB treatment can come with catastrophic costs

Even before the costs of getting diagnosed, picked up in some high-tuberculosis incidence countries by patients themselves, and even before treatment brings its own costs, the financial toll of tuberculosis has already begun, a representative of the World Health Organization said today.

Published
26 October 2016
From
Science Speaks
2016 Report on Tuberculosis Research Funding Trends, 2005–2015: No Time To Lose

Tuberculosis (TB) killed 1.8 million people in 2015, making it the most deadly infectious disease worldwide, but funding for research into better TB prevention, diagnosis, and treatment dropped by US$53.4 million, according to Treatment Action Group’s 2016 Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose.

Published
26 October 2016
From
Treatment Action Group
← First12345...102Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.